TY - JOUR
T1 - Small-angle X-ray scattering studies on structures of an estrogen-related receptor α ligand binding domain and its complexes with ligands and coactivators
AU - Jin, Kyeong Sik
AU - Park, Joon Kyu
AU - Yoon, Jinhwan
AU - Rho, Yecheol
AU - Kim, Jae Hong
AU - Kim, Eunice Eun Kyeong
AU - Ree, Moonhor
PY - 2008/8/14
Y1 - 2008/8/14
N2 - We have investigated the structure of the mouse estrogen-related receptor α ligand binding domain (mERRα LBD) with a flexible hinge region (including more than 30 residues) in solution and the variations of its structure in response to binding with various ligands and coactivators by using synchrotron small-angle X-ray scattering (SAXS) and biochemical analysis. The mERRα LBD alone and in complex with the domain containing all three leucine-rich repeats of human peroxisome proliferator-activated receptor γ coactivator-1α (hPGC-1α) were both cloned and expressed in Escherichia coli and purified to homogeneity. We also synthesized steroid receptor coactivator-1 (SRC-1), a 15-mer peptide corresponding to the leucine-rich repeat 4 of human SRC-1. We tested 4-hydroxytamoxifen, diethylstilbestrol, chlordane, genistein, daidzein, and biochanin A as ligands. SAXS and biochemical analyses were used to show that the apo mERRα LBD is present as a homodimer in solution. The apo mERRα LBD homodimer has an asymmetrically ellipsoidal shape with a lower region that includes the extended hinge domain. It was found that the homodimer always undergoes some structural changes in cooperation with the hinge domain when it binds with ligands. These structural changes are probably due to changes in the conformation of the mERRα LBD ligand binding pocket, which has a relatively small volume when ligand bindings occur. Overall, all the tested ligands have similar impacts on the structure of the mERRα LBD. In contrast, the mERRα LBD:hPGC-1α complex has a Y-shaped structure, which is quite different from the structures of the mERRα LBD bound with ligands. This result provides important information about the spatial orientation of the flexible disordered and/or relatively rigid regions bearing all three L1, L2, and L3 motifs of the partially unfolded hPGC-1α fragments, which are involved in the interaction with the mERRα LBD. The mERRα LBD was found to have a strong binding affinity with the hPGC-1α coactivator fragment, which arises from the cooperativity of the three leucine-rich motifs in the coactivator binding mode. In contrast, the mERRα LBD complex with SRC-1 was found to have a structure very similar to that of the apo mERRα LBD, which provides a foundation for a ligand-independent understanding of the constitutively transcriptional activity of apo ERRs.
AB - We have investigated the structure of the mouse estrogen-related receptor α ligand binding domain (mERRα LBD) with a flexible hinge region (including more than 30 residues) in solution and the variations of its structure in response to binding with various ligands and coactivators by using synchrotron small-angle X-ray scattering (SAXS) and biochemical analysis. The mERRα LBD alone and in complex with the domain containing all three leucine-rich repeats of human peroxisome proliferator-activated receptor γ coactivator-1α (hPGC-1α) were both cloned and expressed in Escherichia coli and purified to homogeneity. We also synthesized steroid receptor coactivator-1 (SRC-1), a 15-mer peptide corresponding to the leucine-rich repeat 4 of human SRC-1. We tested 4-hydroxytamoxifen, diethylstilbestrol, chlordane, genistein, daidzein, and biochanin A as ligands. SAXS and biochemical analyses were used to show that the apo mERRα LBD is present as a homodimer in solution. The apo mERRα LBD homodimer has an asymmetrically ellipsoidal shape with a lower region that includes the extended hinge domain. It was found that the homodimer always undergoes some structural changes in cooperation with the hinge domain when it binds with ligands. These structural changes are probably due to changes in the conformation of the mERRα LBD ligand binding pocket, which has a relatively small volume when ligand bindings occur. Overall, all the tested ligands have similar impacts on the structure of the mERRα LBD. In contrast, the mERRα LBD:hPGC-1α complex has a Y-shaped structure, which is quite different from the structures of the mERRα LBD bound with ligands. This result provides important information about the spatial orientation of the flexible disordered and/or relatively rigid regions bearing all three L1, L2, and L3 motifs of the partially unfolded hPGC-1α fragments, which are involved in the interaction with the mERRα LBD. The mERRα LBD was found to have a strong binding affinity with the hPGC-1α coactivator fragment, which arises from the cooperativity of the three leucine-rich motifs in the coactivator binding mode. In contrast, the mERRα LBD complex with SRC-1 was found to have a structure very similar to that of the apo mERRα LBD, which provides a foundation for a ligand-independent understanding of the constitutively transcriptional activity of apo ERRs.
UR - http://www.scopus.com/inward/record.url?scp=50549093468&partnerID=8YFLogxK
U2 - 10.1021/jp800120r
DO - 10.1021/jp800120r
M3 - Article
AN - SCOPUS:50549093468
SN - 1520-6106
VL - 112
SP - 9603
EP - 9612
JO - Journal of Physical Chemistry B
JF - Journal of Physical Chemistry B
IS - 32
ER -